Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir.

Clinical journal of gastroenterology - 1 Aug 2023

Matsumoto Kotaro, Kikuchi Kentaro, Namura Yuta, Watanabe Ayako, Tsunashima Hiromichi, Doi Shinpei

Abstract excerpt

A 60-year-old man with type-2 diabetes and chronic hepatitis C (HCV) was diagnosed with single hepatocellular carcinoma (HCC) of 67 mm in the hepatic posterior right lobe. Lenvatinib 8 mg was initiated but discontinued because of grade 3 liver injury. The patient continued to have prolonged liver injury and persistently high immunoglobulin G levels. Antinuclear antibody titer increased from 1:40 to 1:320....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis, Autoimmune

Share to Hepatitis C

Share to Hepatitis C, Chronic

Share to Liver Neoplasms

Source

Identifiers

PMID: 37118643
DOI: 10.1007/s12328-023-01809-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir.PMID 37118643Read ↗

Application of Histopathology, Immunohistochemistry, and Antibody Titers in the Diagnosis and Treatment Response Assessment of Autoimmune Liver DiseasesSemantic proximity Read ↗

Cutting edge issues in autoimmune hepatitis.Semantic proximity Read ↗

Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature.Semantic proximity Read ↗

Unveiling the Cholestatic Phenotype: A Case Report of Autoimmune Hepatitis with Severe HyperbilirubinemiaSemantic proximity Read ↗

Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Semantic proximity Read ↗

Characteristics and Long-term Outcome of 535 Patients with Histologically Confirmed Autoimmune Hepatitis (AIH) - A Single Center Experience of 18 YearsSemantic proximity Read ↗

Severe Liver Injury Associated with Glecaprevir Plus Pibrentasvir Therapy in a Patient with Treatment-naïve Hepatitis C Virus Infection.Semantic proximity Read ↗

CD4+Foxp3+CD25+/- Tregs characterize liver tissue specimens of patients suffering from drug-induced autoimmune hepatitis: A clinical-pathological study.Semantic proximity Read ↗

Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities.Semantic proximity Read ↗

The development of type-1 autoimmune hepatitis after chronic hepatitis C (HCV) clearance by direct-acting antivirals (DAA).Semantic proximity Read ↗

Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis A cohort studySemantic proximity Read ↗

Emperipolesis is a potential histological hallmark associated with chronic hepatitis B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.